SHH · 600186.SS
Lotus Health Group Company
CN¥8.67-CN¥0.02 (-0.23%)
Lotus Health Group Company’s quoted price sits in the lower half of its reported 52-week range, 45.57% below the high.
Loading market information…
SHH · 603193.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 03:29 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Runben Biotechnology’s quoted price sits in the lower half of its reported 52-week range, 37.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Runben Biotechnology’s forward annual dividend is CN¥0.56 per share, paid semi-annual. The forward yield is 3.32% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Runben Biotechnology’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Runben Biotechnology Co., Ltd. focuses on the creation, production, and distribution of mosquito repellent solutions, infant care items, and essential oil products. The company primarily sells its offerings through digital sales channels. Established in 2013, Runben Biotechnology is headquartered in Guangzhou, China, and functions as a division of Guangzhou Zhuofan Investment Holding Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:15 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 |
|---|
| Apr 24, 2025 |
| CN¥0.10-23.08% vs estimate |
| CN¥281.00M+17.08% vs estimate |
| Q1 2025 | Apr 24, 2025 | CN¥0.110.0% vs estimate | CN¥240.03M+0.01% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥8.67-CN¥0.02 (-0.23%)
Lotus Health Group Company’s quoted price sits in the lower half of its reported 52-week range, 45.57% below the high.
CN¥22.46+CN¥0.76 (+3.5%)
Kuaijishan Shaoxing Rice Wine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.32% below the high.
CN¥7.66-CN¥0.15 (-1.92%)
TECON BIOLOGY Co.LTD’s quoted price sits in the upper half of its reported 52-week range, 10.2% below the high.
CN¥7.10-CN¥0.09 (-1.25%)
Shandong Yisheng Livestock & Poultry Breeding Co., Ltd. Class A’s quoted price sits in the lower half of its reported 52-week range, 35.4% below the high.
CN¥11.39+CN¥0.19 (+1.7%)
Sanquan Food Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.37% below the high.
CN¥23.20+CN¥0.96 (+4.32%)
Chongqing Baiya Sanitary Products Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 7.13% below the high.
CN¥24.36+CN¥0.17 (+0.7%)
Guangdong Marubi Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 34.22% below the high.
CN¥7.49+CN¥0.16 (+2.18%)
C&S Paper Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 19.03% below the high.
